Hepatitis C: Reducing Incidence
|
|
- Hope Jordan
- 7 years ago
- Views:
Transcription
1 Hepatitis C: Reducing Incidence Brian R. Edlin, MD, FACP, FIDSA Senior Principal Investigator National Development and Research Institutes Associate Professor of Medicine Weill Cornell Medical College New York, New York National Summit to Improve Access to HCV Testing, Treatment, and Cure Centers for Disease Control and Prevention Atlanta, GA June 17-18, 2014 `
2 Hepatitis C Control Pillars of Disease Control Epidemiology Prevention Testing Treatment Surveillance Research
3 Hepatitis C Control National Summit to Improve HCV Testing, Treatment, and Cure Epidemiology Prevention Testing Treatment Surveillance Research
4 Hepatitis C Control National Summit to Improve HCV Testing, Treatment, and Cure Epidemiology Prevention Testing Treatment Surveillance Research
5 People Who Inject Drugs: the Core of the Hepatitis C Epidemic Largest group of infected persons Source of most HCV transmission Highest prevalence (50%-90%) Highest incidence (10%-40% per year) Approx. one million people who inject drugs in U.S. have hepatitis C. Few people who inject drugs are in care; even fewer receive treatment.
6 Effective HCV Prevention Interventions Community-Based Outreach Education Sterile Syringe Access Voluntary Testing and Counseling Treatment for Substance Use
7 HCV Antibody Prevalence, Urban Health Study, San Francisco, 1987 Percent anti-hcv positive Year of Testing Duration of Injection Drug Use (Years) Lorvick Am J Public Health 2001;91:46-7.
8 HCV Antibody Prevalence, Urban Health Study, San Francisco, 1987 Percent anti-hcv positive Year of Testing 1987 Prevalence > 80% after 1 year of injecting Incidence = 15 per 100 person-months Duration of Injection Drug Use (Years) Lorvick Am J Public Health 2001;91:46-7.
9 HCV Antibody Prevalence, Urban Health Study, San Francisco Bay Area, 1987, Percent anti-hcv positive 50 Year of Testing Duration of Injection Drug Use (Years) Lorvick Am J Public Health 2001;91:46-7, Tseng Hepatology 2007;46:666-71
10 Changing Risk of Acquiring HCV Infection, Street- Recruited PWIDs, San Francisco, Odds Ratio Bacchetti BMC Infect Dis 2007; 7:145 Year
11 HCV Antibody Prevalence, Street-Recruited People Who Inject Drugs, New York, Percent anti-hcv positive Swan Project 0 < Duration of Injection Drug Use (Years)
12 HCV Prevalence among Young People Who Inject Drugs Author Location Study Year Time to 50% Prevalence Garfein Baltimore REACH 1988 <1 year Lorvick San Francisco UHS 1987 <1 year Thorpe Chicago CIDUS years Diaz New York CIDUS years Hahn San Francisco UFO years Garfein Am J Public Health 1996;86:655. Lorvick Am J Public Health 2001;91:46. Thorpe J Infect Dis 2000;182:1588. Diaz Am J Public Health 2001;91:23. Hahn Hepatology 2001;34:180.
13 Effect of HIV Prevention Interventions on HCV Transmission 1980 s: 80% infected/6-8 mos. = 15%-20%/month 1990 s and 2000 s: 10%-25%/year Edlin Nature 2011; 474: S18-9
14 Effect of HIV Prevention Interventions on HCV Transmission 1980 s: 80% infected/6-8 mos. = 15%-20%/month 1990 s and 2000 s: 10%-25%/year Introduction of evidence-based HIV prevention interventions: Community-Based Outreach Testing and Counseling Sterile Syringe Access Substance Use Treatment Edlin Nature 2011; 474: S18-9
15 Effect of HIV Prevention Interventions on HCV Transmission 1980 s: 80% infected/6-8 mos. = 15%-20%/month 1990 s and 2000 s: 10%-25%/year Introduction of evidence-based HIV prevention interventions: Community-Based Outreach Testing and Counseling Sterile Syringe Access Substance Use Treatment Edlin Nature 2011; 474: S18-9 Insufficient Ineffective
16 Hepatitis C: Where is it Spreading? People who inject drugs HIV-infected men who have sex with men Unsafe injection practices in medical settings Vertical transmission Young people using pharmaceutical opioids Yaphe Sex Transm Infect 2012;88:558. Thompson Ann Intern Med 2009;150:33. Perz Clin Liver Dis 2010;14:137. Benova Clin Infect Dis Suryaprasad Clin Infect Dis. OHAIDP Havens Am J Public Health 2013;103:e44. Young Epidemiol Infect 2013;141:402. Bruneau Addiction 2012;107:1318. MMWR 2012;61:358. MMWR 2011;60:1457. MMWR 2008;57:517.
17 Nonmedical Opioid Use and Sequelae, United States, Volkow ND et al. N Engl J Med 2014;370: Source: CDC, SAMHSA, DEA
18 Reaching Newly Affected Groups Prescription Opioid Users Five million young people used pharmaceutical opioids in past year Many are in rural and suburban locations Transition to heroin injection is common Opioid overdoses are epidemic and signal HCV transmission HCV outbreaks reported to CDC in 13 states We can intervene now or watch the epidemic unfold.
19 Effective HCV Prevention Interventions Community-based outreach Education Sterile syringe access Other injection equipment Voluntary testing and counseling Treatment for substance use (buprenorphine) Pharmacy syringe access and education Internet and social media Law enforcement, jails, prisons Multicomponent interventions Harm reduction Peer-driven interventions Financial incentives Antiviral treatment Education to prevent reinfection
20 Effective HCV Prevention Interventions Community-based outreach Education Sterile syringe access Other injection equipment Voluntary testing and counseling Treatment for substance use (buprenorphine) Pharmacy syringe access and education Internet and social media Law enforcement, jails, prisons Multicomponent interventions Harm reduction Peer-driven interventions Financial incentives Antiviral treatment Education to prevent reinfection
21 Reaching Newly Affected Groups Prescription Opioid Users Multicomponent interventions Outreach, education, counseling, testing, linkage to care Test negative prevention Test positive treatment Epidemiology and surveillance simultaneously with providing services We can intervene now or watch the epidemic unfold.
22 Reaching Newly Affected Groups Prescription Opioid Users Collaboration (and cross-training): Federal, state, local public health agencies Harm reduction and outreach experts Hepatitis C specialists Mental health and substance use treatment providers Primary care Pharmacists Law enforcement authorities Criminal justice Affected communities (people using illicit drugs)
23 Reaching Newly Affected Groups Prescription Opioid Users Harm reduction Respect, nonjudgment, cultural competence Persons in target groups are the experts Full collaboration of affected communities in defining and implementing needed interventions
24 Hepatitis C Virus Incidence in Young People Who Inject Drugs The Swan Project, New York, N Person- Days HCV HCV incidence per 100 person-years (95% CI) P Age years 78 11, (19.8, 64.6) years 74 12, (15.9, 55.0) years 55 10, (7.4, 42.9) 30+ years 42 9, (0.0, 0.0) Duration of injection drug use <0.5 years 22 1, (25.4, 243.7) 1 year 56 6, (15.6, 77.3) 2-9 years , (13.3, 35.5) 10+ years 37 8, (0.6, 29.6) Total , (14.9, 32.2)
25 Hepatitis C Virus Incidence in Young People Who Inject Drugs The Swan Project, New York, N Person- Days New HCV Infections HCV Incidence per 100 person-years (95% CI) P Sex 0.25 Men , (17.6, 41.4) Women 68 13, (5.5, 31.8) Follow-up (after enrollment) days , (30.1, 82.8) days 148 7, (7.6, 54.0) >120 days , (4.8, 21.3) Total , (14.9, 32.2)
26 Effective Outreach to Hidden Populations Field Methods Community-based locations Environment free of judgment, shame, or stigma Staff knowledgeable about drug use and users and hepatitis C Client-centered focus Services counseling, testing, harm reduction Cash incentives Hard-to-reach populations are easy to reach when programs are designed to meet their needs.
27 Reaching Newly Affected Groups Prescription Opioid Users Antiviral Treatment Everyone who is infected needs access to treatment To prevent disease, treat those at risk of progression To prevent spread, treat those at risk of transmission Governments, payers, and pharmaceutical industry must agree: Everyone who needs antiviral therapy for hepatitis C must have access to it. Education to prevent reinfection
28 Preventing HCV Reinfection after SVR in People Who Inject Drugs Author Year N Reinfections Rate per 100 person-years (95% CI) Backmund (0.5,14) Dalgard (0.0,4.7) Currie (0.1,15) Grebely (0.4,12) Grady (0.0,4.2) Aspinall (0.9,6.1) Choices (NY) Aspinall Clin Infect Dis 2013;57:S80
29 Hepatitis C: Preventing New Infections New regimens offer the promise of eliminating HCV A national consensus is needed to make this happen. Outreach Seek Test Treat Cure Prevent Intervention will require effort and resources. We can intervene now or watch the epidemic unfold.
Bringing Hepatitis C Treatment into the Medical Home
Bringing Hepatitis C Treatment into the Medical Home Dr. Joanna Eveland MS, MD, Clinical Chief for Special Populations Mission Neighborhood Health Center, San Francisco, CA The Challenge: Hepatitis C Virus
More informationThe Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section
The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who
More informationCase Finding for Hepatitis B and Hepatitis C
Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center
More informationPlacing Nation on the Path Toward the Elimination of Hepatitis C
Placing Nation on the Path Toward the Elimination of Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Division of Viral Hepatitis National Center for
More informationStrengthening the HCV Continuum of Care
Strengthening the HCV Continuum of Care Fabienne Laraque, MD, MPH, Medical Director Viral Hepatitis Surveillance, Prevention and Control Bureau of Communicable Diseases Control, NYC DOHMH March 18, 2014
More informationEpidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid
Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.
More informationHCV Telehealth Training Program Challenges and benefits of integrating hepatitis C care into a primary care setting
HCV Telehealth Training Program Challenges and benefits of integrating hepatitis C care into a primary care setting Takako Schaninger, MD Program Director Southern Central AIDS Education Telehealth Training
More informationPopulations at risk for opioid overdose
Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April
More informationTestimony of The New York City Department of Health and Mental Hygiene. before the
Testimony of The New York City Department of Health and Mental Hygiene before the New York City State Assembly Committee on Alcoholism and Drug Abuse on Programs and Services for the Treatment of Opioid
More informationNaloxone: Overview, Criminal Justice and other Special Settings
Naloxone: Overview, Criminal Justice and other Special Settings Ingrid Binswanger, MD, MPH, MS Division of General Internal Medicine Affiliated Member, Division of Substance Dependence University of Colorado
More informationHepatitis C Infections in Oregon September 2014
Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with
More informationDave Burrows Director
Dave Burrows Director Effects of drug policy on HIV transmission What is the Comprehensive Package of Services for People Who Inject Drugs (PWID) What is an enabling environment for addressing HIV among
More informationIN THE SENATE OF THE UNITED STATES , 2003. M. introduced the following bill; which was referred to the Committee on A BILL
DRAFT //0 0TH CONGRESS ST SESS. S. To direct the Secretary of Health and Human Services to establish, promote, and support a comprehensive program for education, prevention, and treatment of Hepatitis
More informationPreface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636)
Preface The purpose of this CDC Hepatitis C Counseling and Testing manual is to provide guidance for hepatitis C counseling and testing of individuals born during 1945 1965. The guide was used in draft
More informationTargeted HIV Testing & Enhanced Testing Technologies. HIV Prevention Section Bureau of HIV/AIDS
Targeted HIV Testing & Enhanced Testing Technologies HIV Prevention Section Bureau of HIV/AIDS May 2012 1 Typing a Question in the Chat Box Type question in here 2 Completing the Webinar Evaluation (opened
More informationTestimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition
Testimony on Opioid Overdose Prevention Daniel Raymond, Policy Director, Harm Reduction Coalition Presented on March 25, 2014 to the House Appropriations Subcommittee on Labor, Health and Human Services,
More informationHepatitis C Virus Infection in Massachusetts: A tale of two epidemics
Hepatitis C Virus Infection in Massachusetts: A tale of two epidemics Daniel Church, MPH Massachusetts Department of Public Health Bureau of Infectious Disease 1 Goals of presentation Provide an overview
More informationChallenges to Hepatitis C Virus (HCV) Care via Telemedicine for Individuals on Opiate Agonist Therapy
Challenges to Hepatitis C Virus (HCV) Care via Telemedicine for Individuals on Opiate Agonist Therapy Andrew Talal, MD, MPH 1 Marija Zeremski, PhD 2 Roberto Zavala, MD 3 Rositsa Dimova, PhD 1 Melissa Lin,
More informationHCV Epidemiology in the United States
HCV Epidemiology in the United States Scott Holmberg, MD, MPH Chief, Epidemiology and Surveillance Branch, DVH, CDC sdh1@cdc.gov A Tale of Two Epidemics Chronic HCV: Rapidly increasing mortality and morbidity
More informationEver wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier?
Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier? Good News: Medical treatments called opioid (oh-pee-oyd) maintenance can help you! Injecting heroin puts you
More informationHARM REDUCTION FOR PEOPLE WHO INJECT DRUGS INFORMATION NOTE
HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS INFORMATION NOTE Introduction The Global Fund supports evidence-based interventions that aim to ensure access to HIV prevention, treatment, care and support for
More informationPresentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
More informationSubstance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
More informationWe include a series of recommended questions for the Swedish delegation at the end of our letter.
United Nations Committee on Economic Social and Cultural Rights Palais Wilson CH 1211 Geneva 10 Switzerland 2 October 2008 Re: Review of Sweden s fifth periodic report, 41 st Session of the Committee on
More informationFigure 2. Estimated Number of People Living with HIV/AIDS (PLWHA) in LAC, 2009. Unaware HIV/AIDS (1) Pending HIV Cases (2) Coded Living HIV
Overview of Los Angeles County Los Angeles County (LAC), at 4,084 square miles, 88 incorporated cities and over 10 million residents, is one of the largest counties in the US, with a population that is
More informationClinical Priorities for Alcohol and Drugs in Public Health
Clinical Priorities for Alcohol and Drugs in Public Health What do we need to Measure up to? Dr Michael Kelleher Clinical Lead Alcohol and Drugs Team, Health and Wellbeing Directorate SMMGP 8 th Primary
More informationPrescriber Behavior, Pain Treatment and Addiction Treatment
Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy
More informationPrescription Drug Abuse and Overdose: Public Health Perspective
Prescription Drug Abuse and Overdose: Public Health Perspective [Residency educators may use the following slides for their own teaching purposes.] CDC s Primary Care and Public Health Initiative October
More informationHepatitis C. Screening, Diagnosis and Linkage to Care
Hepatitis C Screening, Diagnosis and Linkage to Care Diagnosis If your hepatitis C antibody test is reactive, a second test will be needed to diagnose and determine if you are currently infected. Screening
More informationRecommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965
Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965 MMWR August 17, 2012 Prepared by : The National Viral Hepatitis Technical Assistance Center
More informationBriefing Note: Hepatitis B & Hepatitis C. Summary:
Briefing Note: Hepatitis B & Hepatitis C Summary: In Canada, hepatitis B and hepatitis C infections remain serious public health concerns due to high prevalence rates, high health care expenditures and
More informationGlobal Under Diagnosis of Viral Hepatitis
Global Under Diagnosis of Viral Hepatitis Mel Krajden MD, FRCPC Medical Head, Hepatitis Clinical Prevention Services Associate Medical Director, Public Health Microbiology & Reference Laboratory BC Centre
More informationScaling Up Riskbased. Screening in the United States
Scaling Up Riskbased Hepatitis C Screening in the United States A report from a Think Tank convened by Project Inform, held September 17 & 18, 2013, Washington, DC Contents Introduction 1 3 Background
More informationAssessing the Costs of Medication-Assisted Treatment for HIV Prevention in Georgia
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Georgia BACKGROUND While post-soviet Georgia has experienced favorable economic, political, and social change in the last two
More informationSIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item 12.3 24 May 2014. Hepatitis
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY WHA67.6 Agenda item 12.3 24 May 2014 Hepatitis The Sixty-seventh World Health Assembly, Having considered the report on hepatitis; 1 Reaffirming resolution WHA63.18,
More informationStrategies to Improve the HCV Continuum of Care:
Strategies to Improve the HCV Continuum of Care: Best Practices in Testing, Linkage to Care & Treatment Ronald O. Valdiserri, M.D., M.P.H. Deputy Assistant Secretary for Health, Infectious Diseases June
More informationThe path forward: How can we develop a rational system for addressing Opioid Use Disorder?
The path forward: How can we develop a rational system for addressing Opioid Use Disorder? Miriam Komaromy, MD, FACP Associate Director, ECHO Institute University of New Mexico Bernalillo County Opioid
More information2016 SUMMER SCHOOL COURSES
2016 SUMMER SCHOOL COURSES June 6-9, 2016, Worcester State University, Worcester, MA This document contains a list of the courses offered at our 2016 Summer School in Addiction and Studies. For the remainder
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationPrescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010
Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence Service Officer Tennessee Department of
More informationIntroduction to Substance Abuse Issues in Canada: Pathways, Health Implications and Interventions
Introduction to Substance Abuse Issues in Canada: Pathways, Health Implications and Interventions Maritt Kirst, PhD Centre for Research on Inner City Health, St. Michael s Hospital OTC Summer Institute
More informationHepatitis Services in Substance Abuse Treatment Settings
Hepatitis Services in Substance Abuse Treatment Settings Funding provided by the Center for Substance Abuse Treatment The Matrix Institute Dan George Overview Hx of HCV group s implementation at OTP clinic
More informationMEDICAL OUTREACH TO HOMELESS SUBSTANCE USERS IN NEW YORK CITY: PRELIMINARY RESULTS*
SUBSTANCE USE & MISUSE Vol. 37, Nos. 8 10, pp. 1269 1273, 2002 MIGRATION, ACCULTURATION, DISPLACEMENT MEDICAL OUTREACH TO HOMELESS SUBSTANCE USERS IN NEW YORK CITY: PRELIMINARY RESULTS* Andrew Rosenblum,Ph.D.,
More informationTraci C. Green, PhD, MSc Jody Rich, MD, MPH
Traci C. Green, PhD, MSc Jody Rich, MD, MPH Strategic Plan highlights Comments & Responses from public, stakeholders Input and discussion Next steps Death rate for U.S. non-hispanic whites (USW), U.S.
More informationThe Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE
The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion Angela Huskey, PharmD, CPE Case Bill is a 47 year old man with a history of low back pain and spinal stenosis Not a real
More informationAlcohol and drugs prevention, treatment and recovery: why invest?
Alcohol and drugs prevention, treatment and recovery: why invest? 1 Alcohol problems are widespread 9 million adults drink at levels that increase the risk of harm to their health 1.6 million adults show
More informationResources for the Prevention and Treatment of Substance Use Disorders
Resources for the Prevention and Treatment of Substance Use Disorders Table of Contents Age-standardized DALYs, alcohol and drug use disorders, per 100 000 Age-standardized death rates, alcohol and drug
More informationREVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS
REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS 1. INTRODUCTION 1.1 Review Process A Partnership for a Better Scotland committed the Scottish Executive to reviewing and investing
More informationAN OVERVIEW OF PROGRAMS FOR PEOPLE WHO INJECT DRUGS
AN OVERVIEW OF PROGRAMS FOR PEOPLE WHO INJECT DRUGS Helgar Musyoki MARPs and Vulnerable Groups Program National AIDs/STI Control Programme November 2012 Background Injection of heroin in Kenya reportedly
More information1. Youth Drug Use More than 40% of Maryland high school seniors used an illicit drug in the past year.
1. Youth Drug Use More than 4% of Maryland high school seniors used an illicit drug in the past year. Any Illicit Drug Alcohol Marijuana Ecstasy Cocaine Percentage of Maryland and U.S. high school seniors
More informationHEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis
HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School
More informationWashington State Interagency Opioid Working Plan
Washington State Interagency Opioid Working Plan INTRODUCTION January 2016 Washington State is currently experiencing an opioid abuse and overdose crisis involving prescription opioids and heroin. Approximately
More informationSTATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that
More informationA Drug Policy for the 21st Century. Office of National Drug Control Policy
A Drug Policy for the 21st Century October 18, 2014 International Nurses Society on Addictions Health Care Reform & Its Impact on Addictions Nursing: Navigating Change through the Rapids David K. Mineta,
More informationComprehensive HIV Prevention for People Who Inject Drugs, Revised Guidance
(PEPFAR) Comprehensive HIV Prevention for People Who Inject Drugs, Revised Guidance July 2010 1 Introduction Section 104A of the Foreign Assistance Act, as added by the U.S. Leadership Against HIV/AIDS,
More informationAnalysis of survey data on the implementation of NICE PH18 guidance relating to needle and syringe provision in England
Analysis of survey data on the implementation of NICE PH18 guidance relating to needle and syringe provision in England Geoff Bates, Lisa Jones, Jim McVeigh Contents Acknowledgements... 4 Abbreviations...
More informationEvidence based Prevention & Treatment Options for Emerging Heroin Use in a Public Health Framework
Evidence based Prevention & Treatment Options for Emerging Heroin Use in a Public Health Framework Benedikt Fischer, PhD Professor, CIHR/PHAC Chair in Applied Public Health & MSFHR Senior Scholar Faculty
More information-HHS Secretary Donna Shalala, 1998
Needle exchange programs can be an effective part of a comprehensive strategy to reduce the incidence of HIV transmission and do not encourage the use of illegal drugs -HHS Secretary Donna Shalala, 1998
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationNew York State Strategic Plan for. Elimination of Mother-to-Child Transmission of HIV
New York State Strategic Plan for Elimination of Mother-to-Child Transmission of HIV Introduction Brief Background New York, once the state with the highest reported number of children with AIDS, has made
More informationEMERGING CLINICAL ISSUE: HEPATITIS C INFECTION IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN
EMERGING CLINICAL ISSUE: HEPATITIS C INFECTION IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN JUNE 2014 INTRODUCTION Approximately 3.2 million individuals in the United States are infected with chronic hepatitis
More informationNaloxone Distribution for Opioid Overdose Prevention
Naloxone Distribution for Opioid Overdose Prevention Caleb Banta-Green PhD, MPH, MSW Alcohol and Drug Abuse Institute, University of Washington Alan Melnick, MD, MPH Clark County Public Health Chris Humberson,
More informationThe Ryan White CARE Act 2000 Reauthorization
POLICY BRIEF january 2001 The Ryan White CARE Act 2000 Reauthorization Overview As the Ryan White CARE Act enters its second decade, it continues to be a critical source of care and services for people
More informationAustralian Federation of AIDS Organisations (AFAO) Primary Health Care Reform
Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform 27 February 2009 1 Introduction The Australian Federation of AIDS Organisations (AFAO) is the peak body for Australia s community
More informationHeroin in Snohomish County: Mortality and Treatment Trends
Heroin in Snohomish County: Mortality and Treatment Trends January 2015 This page left intentionally blank. Table of Contents Introduction and Acknowledgments 1 Executive Summary 2 Mortality Overdose Mortality
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical
More informationDesigning Clinical Addiction Research
Designing Clinical Addiction Research Richard Saitz MD, MPH, FACP, FASAM Professor of Medicine & Epidemiology Boston University Schools of Medicine & Public Health Director, Clinical Addiction, Research
More informationTestimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment
Testimony of Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment New York City Department of Health and Mental Hygiene before the New York City
More informationPositive impact of HCV treatment initiation on health outcomes in injecting drug users
Positive impact of HCV treatment initiation on health outcomes in injecting drug users Perrine ROUX, PhD Substance Use Research Center, Columbia University, NY Inserm U912, SE4S, Marseille Introduction
More informationTreatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism
Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine University
More informationHepatitis C Virus: National Trends and Prevention Recommendations
Hepatitis C Virus: National Trends and Prevention Recommendations John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Division of Viral Hepatitis National Center for
More informationDrug Situation in Vancouver UHRI. Report prepared by the Urban Health Research Initiative of the British Columbia Centre for Excellence in HIV/AIDS
Drug Situation in Vancouver Report prepared by the Urban Health Research Initiative of the British Columbia Centre for Excellence in HIV/AIDS Second edition June 2013 UHRI U R BAN H EALTH R ESEARCH I NITIATIVE
More informationHepatitis C Treatment For Injecting Drugs
UPDATED 15. 5. 2015 PERSPECTIVES ON DRUGS Hepatitis C treatment for injecting drug users Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common
More informationHerding Birds The Recruitment and Retention of a Highly Disenfranchised Population
Herding Birds The Recruitment and Retention of a Highly Disenfranchised Population Caycee K. Cullen 1, Alice K. Asher, RN, Ph.D.(c) 1, Ellen S. Stein, MPH 1, Paula J. Lum, MD 2, MPH 2, Kimberly Page, PhD,
More informationTechnical Consultation Hepatitis C Virus Infection in Young Persons Who Inject Drugs. February 26 27, 2013 Consultation Report
Technical Consultation Hepatitis C Virus Infection in Young Persons Who Inject Drugs February 26 27, 2013 Consultation Report This report was prepared under the direction of the U.S. Department of Health
More informationFederal Government Standing Committee on Health
Federal Government Standing Committee on Health Inquiry into Hepatitis C in Australia Professor Gregory Dore Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Australia Infectious
More informationInjection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results David W. Forrest, Ph.D. Marlene LaLota, M.P.H. John-Mark Schacht Gabriel A. Cardenas, M.P.H. Lisa Metsch, Ph.D. National HIV Behavioral
More informationCME Article Hiv Disease Surveillance
CME Article Hiv Disease Surveillance hiv disease surveillance cme Collaboration between Medicine and Public Health Sindy M. Paul, md, mph; Helene Cross, phd; Linda Dimasi, mpa; Abdel R. Ibrahim, phd; and
More informationCHAPTER 10. 1. Section 3 of P.L.2013, c.46 (C.24:6J-3) is amended to read as follows:
CHAPTER 10 AN ACT concerning overdose prevention and sterile syringe access programs, and amending P.L.2006, c.99 and P.L.2013, c.46. BE IT ENACTED by the Senate and General Assembly of the State of New
More informationHow To Reduce High Risk Behavior In Injection Drug Users Through Syringe Exchange
Alex Willard HWP 455.002 Research Paper November 17, 2010 Reducing High Risk Behavior in Injection Drug Users Through Syringe Exchange For prevention of transmission of the Human Immunodeficiency Virus
More informationUnderstanding Hepatitis C Treatment Access
Understanding Hepatitis C Treatment Access Robert Greenwald, JD, Clinical Professor of Law & Director, Center for Health Law and Policy Innovation of Harvard Law School May 2015 Comments Based on Findings
More informationEXECUTIVE SUMMARY. The Report
EXECUTIVE SUMMARY The purpose of this report is to provide a snapshot of substance dependency, and its related costs, for Barnstable County, Massachusetts. The report is intended to inform programming
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationScience addressing drugs and HIV: State of the Art. Vienna
Science addressing drugs and HIV: State of the Art 2 nd Scientific Statement: March 2016 Vienna Context In March 2014, UNODC organized within the frame of the High-level Review of the 57 th session of
More informationHIV and AIDS in Bangladesh
HIV and AIDS in Bangladesh BACKGROUND The first case of HIV/AIDS in Bangladesh was detected in 1989. Since then 1495 cases of HIV/AIDS have been reported (as of December 2008). However UNAIDS estimates
More informationLancet Device Incident Investigation Report - 2012
Lancet Device Incident Investigation Report - 2012 Summary On May 16, 2012 the Winnipeg Regional Health Authority (WRHA) received notification from the University of Manitoba (U of M) of an incident at
More informationHepatitis C: Epidemiology, Transmission, and Screening. Jennifer Price, MD Assistant Professor of Medicine University of California San Francisco
Activity Code FA376 Hepatitis C: Epidemiology, Transmission, and Screening Jennifer Price, MD Assistant Professor of Medicine University of California San Francisco Learning Objectives Upon completion
More informationDrug treatment in East and SE Asia: - the need for effective approaches
Drug treatment in East and SE Asia: - the need for effective approaches Professor Nick Crofts Director, Turning Point Alcohol and Drug Centre Director, UNODC Technical Resource Centre for Drug Treatment
More informationFree Additional Resources
Free Additional Resources Substance Abuse and Mental Health Services Administration Treatment Improvement Protocols The Substance Abuse and Mental Health Services Administration (SAMHSA) offers free Treatment
More informationHepatitis C Prevention through Injection Safety. Evelyn McKnight, president www.honoreform.org
Hepatitis C Prevention through Injection Safety Evelyn McKnight, president www.honoreform.org Unsafe injections spread disease The only national advocacy organization dedicated to safeguarding the medical
More informationBloodborne Pathogens (HIV, HBV, and HCV) Exposure Management
Bloodborne Pathogens Exposure Policy and Procedures Employees of the State of South Dakota Department of Health Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management PEP Hotline 1-888-448-4911 DOH
More informationFederal Response to Opioid Abuse Epidemic
Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government
More informationSubstance Abuse Treatment Evaluations and Interventions Program
Substance Abuse Treatment Evaluations and Interventions Program Project Highlights: HIV Interventions in North Carolina Wendee Wechsberg, Ph.D. SATEI Program Director RTI International 3040 Cornwallis
More informationNew York State Hepatitis C Coalition. Ending the Hepatitis C Epidemic in New York 2015 Policy Recommendations. Hepatitis C in New York the Facts
New York State Hepatitis C Coalition Ending the Hepatitis C Epidemic in New York 2015 Policy Recommendations Hepatitis C in New York the Facts Hepatitis C virus (HCV) infection is the leading cause of
More informationThe Current State of Drug Abuse Across the Nation. December 12, 2015
The Current State of Drug Abuse Across the Nation December 12, 2015 Agenda The Partnership for Drug-Free Kids The macro picture Opioid abuse and addiction What can we do about it? Moving upstream: connecting
More informationUsing Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services
Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services ADP Training Conference, Sacramento, August 21, 2012 Rachel McLean, MPH, CA Dept. of Public
More informationDoes referral from an emergency department to an. alcohol treatment center reduce subsequent. emergency room visits in patients with alcohol
Does referral from an emergency department to an alcohol treatment center reduce subsequent emergency room visits in patients with alcohol intoxication? Robert Sapien, MD Department of Emergency Medicine
More informationInjection Drug Use, HIV and HCV Infection in Ontario: The Evidence 1992 to 2004
> Injection Drug Use, HIV and HCV Infection in Ontario: The Evidence 1992 to 2004 Peggy Millson, MD, FRCPC 1 Lynne Leonard, PhD, CQSW 2 Robert S. Remis, MD, MPH, FRCPC 1 Carol Strike, PhD 3 Laurel Challacombe,
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy
More informationInternational Support for Harm Reduction
International Support for Harm Reduction An overview of multi-lateral endorsement of harm reduction policy and practice Prepared by International Harm Reduction Association and Human Rights Watch 19 January
More information